key: cord-0867444-gfhecglk
authors: Chakhtoura, M.; El Hajj Fuleihan, G.
title: Reply to Vitamin D deficiency in COVID-19: mixing up cause and consequence
date: 2020-12-07
journal: Metabolism
DOI: 10.1016/j.metabol.2020.154462
sha: 047bdedc6d500d1602d174e5c46ed37bbeb4df8c
doc_id: 867444
cord_uid: gfhecglk

nan

Reply to Vitamin D deficiency in COVID-19: mixing up cause and consequence

The SARS-Cov-2 tsunami has engulfed the global community into an accelerated search for preventive and therapeutic strategies to halt its devastating toll; immune modulation being the fulcrum of all. The effect of vitamin D role on innate and adaptive immunity is undisputable [1] , yet its role in this viral illness is unclear [2] . While biologic plausibility supports an association between vitamin D status and COVD-19 infection, establishing causality remains elusive. It was not implied in our commentary [3] . COVID-19 patients often seek medical advice after the onset of symptoms, and past the trigger of its inflammatory cascade. We concur with Smolders et al., reverse causality is a consideration [4] .

These authors show that the inoculation of 9 healthy volunteers with E.Coli-derived lipopolysaccharide, at a relatively high dose of 4 ng/kg over 4 h [5] , resulted in a rise in inflammatory markers, and a concomitant drop in mean serum 25-hydroxyvitamin D (25OHD), by 2.6 ng/ml, 2-3 h later [4] . Several other small studies (N 19-90) examined changes in 25OHD in acute illnesses, using for the most part standardized assays. These included elective orthopedic [6, 7] , and cardiac surgery [8] , acute pancreatitis [9] , or shock and ICU admissions [10, 11] . The drop in mean 25OHD of 1-12 ng/ml occurred during the first 48 h of admission [6] [7] [8] [9] [10] [11] . The response was however quite variable, some studies registering no change or an increase [9, 12] . Serum 25OHD level may return to baseline within 5-14 days [6, 8, 9] , but this return was not linked to recovery from illness [12] . Both 25OHD and 1,25OH 2 D decreased similarly by day 5 in one study, but while 25OHD returned to baseline, there was a subsequent overshoot in 1,25OH 2 D level [8] .

The reasons for decrements in 25OHD level in acute illness are not clear. The association of CRP and albumin, most frequently assessed predictors for a change in 25OHD during illness, were inconsistent [6] [7] [8] [9] . The dilutional effects of fluids during illness [6] , a drop in vitamin D binding protein (VDBP) [7] , and a possible increase in 1-α hydroxylation of 25OHD [9] , may all contribute. Free 25OHD may also be affected. In a study of 33 patients undergoing knee arthroplasty, levels of total and free 25OHD, and VDBP, decreased by 40% and 15%, respectively, starting day 1 post-operatively [6] .

The collider effect challenges association studies, reverse causality is one of them [13] . The severity of COVID-19 infection affects the decision for hospitalization, and causal inferences in hospitalized patients might not be well-grounded [13] . A thorough assessment of the evidence available, with particular attention to matters relevant to 25OHD assays [14] , reverse causality, and quality assessment, is crucial [15] . Such scrutiny provides the framework to provide guidance on vitamin D supplementation, given in a preventive or adjuvant-therapy mode, in the Metabolism Clinical and Experimental 115 (2021) 154462 spectrum of COVID-19 illnesses. Well conducted observational studies will also provide the basis, when coupled with forthcoming evidence from vitamin D randomized controlled trials where vitamin D effect may be confounded by the standard use of steroids, to confirm or refute the putative role of vitamin D in Covid-19 illnesses.

None

Key vitamin D target genes with functions in the immune system

The trinity of COVID-19: immunity, inflammation and intervention

Commentary: myths and facts on vitamin D amidst the COVID-19 pandemic

Vitamin D deficiency in COVID-19: mixing up cause and consequence. Metabolism, Clinical and Experimental

Intravenous endotoxin challenge in healthy humans: an experimental platform to investigate and modulate systemic inflammation

The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty

Vitamin D: a negative acute phase reactant

Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients

Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study

Fall in vitamin D levels during hospitalization in children

Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality

Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction

Collider bias undermines our understanding of COVID-19 disease risk and severity

Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration

The link between corona vIruses and VItamin D (VIVID): an extensive and rigorous systematic review and meta-analysis